Ticagrelor

Antiplatelet drugs are the cornerstone of treatment for patients with acute coronary syndromes (ACS) who undergo percutaneous coronary intervention. Clopidogrel and aspirin improve long-term clinical outcomes in these patients and have become a standard of care. However, many patients still experien...

Full description

Bibliographic Details
Main Authors: Gianluca Airoldi, Mauro Campanini
Format: Article
Language:English
Published: PAGEPress Publications 2013-03-01
Series:Italian Journal of Medicine
Subjects:
Online Access:http://www.italjmed.org/index.php/ijm/article/view/150